Not applicableUnknownNCT03958188What this trial is testingPreOPerative Imaging of NeuroEndocrine TumorsWho this might be right forNeuro-endocrine TumorsSmall Intestine Cancer Hospices Civils de Lyon 47
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Not applicableWithdrawnNCT01936961What this trial is testingStudy of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid TumorsWho this might be right forMetastatic Non-Small Cell Lung CancerMetastatic Colon CancerMetastatic Triple Negative Breast Cancer Western Regional Medical Center
Early research (Phase 1)Study completedNCT00006009What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaWho this might be right forLymphomaSmall Intestine Cancer Stanford University
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00006357What this trial is testingSTI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaWho this might be right forEndometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 91
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06128551What this trial is testingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma Revolution Medicines, Inc. 534
Not applicableStudy completedNCT00963911What this trial is testingValidation of a Screening Tool in Geriatric OncologyWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+3 more Institut Bergonié 1,674
Early research (Phase 1)Active Not RecruitingNCT06147037What this trial is testingA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more AstraZeneca 13
Testing effectiveness (Phase 2)Study completedNCT00006039What this trial is testingInterferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphomaSmall Intestine Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05780307What this trial is testingIMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer+3 more ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 48
Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Early research (Phase 1)Ended earlyNCT04000529What this trial is testingPhase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesWho this might be right forNon-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more Novartis Pharmaceuticals 122
Early research (Phase 1)Ended earlyNCT04042480What this trial is testingSGN-CD228A in Advanced Solid TumorsWho this might be right forCutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more Seagen Inc. 88
Not applicableLooking for participantsNCT06227728What this trial is testingAnalysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.Who this might be right forNon Small Cell Lung CancerBreast CancerColorectal Cancer+4 more Gene Solutions 50